drugset / Trial / NCT02966860

Single-Dose PK Study of an Oxycodone/Acetaminophen Solution in Healthy Subjects

NCT02966860

Phase 1 Completed 18 enrolled Mallinckrodt
NaSingle-groupOpen-labelBasic science

Summary

A single-dose study evaluating the oral PK of an oxycodone/apap solution in healthy subjects under fasted conditions

Timeline

Start
2016-08
Primary completion
2016-09
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 975 mg Oral
Subject Oxycodone Other / unclassified 15 mg Oral

Indications

No indication recorded.